Halofantrine
Antimalarial — ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Also known as: halfan, halofantrine HCl, halofantrine hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Halofantrine is an ofm drug in the Antimalarial class catalogued in DrugCentral. It was first approved by the FDA in 1992. DrugCentral lists 1 molecular target, including KCNH2. Recorded indications include Falciparum malaria and Vivax malaria.
- Approval status: ofm (first approved 1992 by the FDA).
- Drug class: Antimalarial.
- Molecular targets: KCNH2 (1 listed in DrugCentral).
- Indications: Falciparum malaria and Vivax malaria.
- ATC code: P01BX01 (Other antimalarials).
- Molecular formula: C26H30Cl2F3NO; molecular weight 500.43 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Falciparum malaria
- Vivax malaria
Contraindications (3)
- Atrioventricular Conduction Defect
- Kidney disease
- Prolonged QT interval
Mechanism & targets
| Established pharmacologic class | Antimalarial |
|---|
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | KCNH2 | unknown | Ki 5.12 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1992-07-24 | FDA | — | GLAXOSMITHKLINE | Yes |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
P01BX01 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTIPROTOZOALS › ANTIMALARIALS › Other antimalarials |
Chemical structure
| Molecular formula | C26H30Cl2F3NO |
|---|---|
| Molecular weight | 500.43 g/mol |
| CAS number | 69756-53-2 |
| InChIKey | FOHHNHSLJDZUGQ-UHFFFAOYSA-N |
| PubChem CID | 37393 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Halofantrine used for?
DrugCentral lists the following indications for Halofantrine: Falciparum malaria and Vivax malaria.
How does Halofantrine work?
Its molecular targets in DrugCentral include KCNH2.
When was Halofantrine first approved?
Halofantrine was first approved by the FDA in 1992.
What drug class does Halofantrine belong to?
Halofantrine is in the Antimalarial class.
What is the chemical formula of Halofantrine?
Halofantrine has the molecular formula C26H30Cl2F3NO and a molecular weight of 500.43 g/mol.
Browse: all drugs starting with H · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1350 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1107 — compound record and bioactivity
- PubChem CID 37393 — chemical identifiers
- DrugBank DB01218 — drug record
- FDA UNII Q2OS4303HZ — substance identity
- DailyMed: FDA labels for Halofantrine — current prescribing information (label search)
- UniProt Q12809 (KCNH2) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.